Skip to content
10-Q

Quarterly Report

BIOETHICS, LTD.

0001477932-24-007440

← back to feed
Filed
Nov 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 19, 2024 1.14M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$78.19K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$16.11K
Cash And Equivalents Q3 2024 · Sep 30, 2024 $17.15K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $138
Stockholders Equity Q3 2024 · Sep 30, 2024 −$862.93K
Stockholders Equity Q3 2024 · Jun 30, 2024 −$851.85K
Stockholders Equity Q3 2024 · Mar 31, 2024 −$815.92K
Stockholders Equity Q3 2024 · Dec 31, 2023 −$776.27K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$751.86K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$729.56K
Stockholders Equity Q3 2024 · Mar 31, 2023 −$702.75K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$679.12K
Current Liabilities Q3 2024 · Sep 30, 2024 $880.09K
Current Liabilities Q3 2024 · Dec 31, 2023 $776.4K
Total Liabilities Q3 2024 · Sep 30, 2024 $880.09K
Total Liabilities Q3 2024 · Dec 31, 2023 $776.4K
Current Assets Q3 2024 · Sep 30, 2024 $17.15K
Current Assets Q3 2024 · Dec 31, 2023 $138
Total Assets Q3 2024 · Sep 30, 2024 $17.15K
Total Assets Q3 2024 · Dec 31, 2023 $138
Sga Expense Q3 2024 · Sep 30, 2024 $39.28K
Sga Expense Q3 2024 · Sep 30, 2024 $89.48K
Sga Expense Q3 2024 · Sep 30, 2023 $10K
Sga Expense Q3 2024 · Sep 30, 2023 $36.84K
Net Income Q3 2024 · Sep 30, 2024 −$53.08K
Net Income Q3 2024 · Sep 30, 2024 −$128.67K
Net Income Q3 2024 · Jun 30, 2024 −$35.93K
Net Income Q3 2024 · Mar 31, 2024 −$39.65K
Net Income Q3 2024 · Sep 30, 2023 −$22.3K
Net Income Q3 2024 · Sep 30, 2023 −$72.75K
Net Income Q3 2024 · Jun 30, 2023 −$26.81K
Net Income Q3 2024 · Mar 31, 2023 −$23.64K
Operating Income Q3 2024 · Sep 30, 2024 −$39.28K
Operating Income Q3 2024 · Sep 30, 2024 −$89.48K
Operating Income Q3 2024 · Sep 30, 2023 −$10K
Operating Income Q3 2024 · Sep 30, 2023 −$36.84K
Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $0